ArticleCureus2026
Unmasking the Silent Invader: A Rare Case of Oral Mucosal Malignant Melanoma With Rapid Multisystem Dissemination.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Oral mucosal melanoma is a rare malignancy of the oral cavity and a small subset of melanomas overall, characterized by an aggressive clinical course and diagnostic challenges. These challenges are particularly pronounced in amelanotic variants due to the lack of pigmentation and their histological resemblance to other spindle cell and epithelial tumors. This report describes a 47-year-old man who presented with a progressively enlarging ulcero-exophytic lesion involving the maxilla and hard palate over nine months, accompanied by cervical lymphadenopathy and rapid development of brain metastasis. Initial histopathological evaluation suggested a spindle cell malignancy; however, immunohistochemical analysis demonstrated positivity for S-100, SOX10, and Melan-A, confirming malignant melanoma. This diagnosis was further supported by repeat biopsy and histopathological findings. Despite treatment with pembrolizumab, the disease progressed rapidly both locally and distantly, necessitating palliative care. This case highlights the persistent challenges in diagnosing oral mucosal melanoma due to its atypical clinical and pathological features, emphasizes the critical role of immunohistochemistry in achieving an accurate diagnosis, and underscores the generally poor prognosis despite current therapeutic options. It also reinforces the importance of early detection and timely multidisciplinary management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.